Oxana Beskrovnaya, Ph.D.

Chief Innovation Officer at Dyne Therapeutics

Speaker

Dr. Oxana Beskrovnaya is Chief Innovation Officer at Dyne Therapeutics, where she leads efforts to advance targeted delivery of oligonucleotides and other therapeutic payloads for neuromuscular diseases. She previously served as Dyne’s Chief Scientific Officer, spearheading development of the FORCE™ platform, which enabled clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1). Prior to Dyne, she held leadership roles at Sanofi and Genzyme, overseeing research in rare diseases across multiple therapeutic modalities. Dr. Beskrovnaya holds a doctorate in genetics from the Moscow Genetics Institute and completed postdoctoral training in neuromuscular diseases with HHMI at the University of Iowa. She is an inventor on numerous patents and has published widely in top-tier journals.